Demetrius Eugene Lee, B.S.1,2, Kristina Vineis, B.S.1,2, Laiz Godoy, M.D.1,2, Lisa Desiderio, RT (R)(MR)1,2, Suyash Mohan, M.D.1,2, and Sanjeev Chawla, Ph.D1,2
1Radiology, Perelman School of Medicine, Philadelphia, PA, United States, 2University of Pennsylvania, Philadelphia, PA, United States
Synopsis
Keywords: Tumors, Blood vessels, Glioma
Evidence has
shown that abnormal iron levels and gliomas are heavily correlated. Due to this, iron presents a possibility to
serve as a glioma biomarker. This study
will utilize susceptibility-weighted imaging (SWI) to identify the glioma, and
quantitative susceptibility mapping (QSM) to explicitly classify iron deposits
in the glioma on an ultra-high field (7T) scanner.
A total of 6
untreated glioma patients with high- and low-grade gliomas underwent 7T
QSM. Patients with high-grade gliomas
showed distinct, geometric iron deposits that low-grade gliomas did not. These results illustrate that 7T QSM may be
helpful in classifying low- and high-grade gliomas.
Introduction
Strong
evidence indicates that abnormal accumulation of heme
(deoxyhemoglobin) and non-heme (ferritin, hemosiderin) iron reflects a multiplicity
of pathological and physiological processes in gliomas. Up-regulation of
transferrin receptor expression has also been observed on glioma cell surface.1,2
Collectively, these studies suggest that iron has the unique potential to serve
as a potential surrogate biomarker for characterizing gliomas. Susceptibility
weighted imaging (SWI) is a
non-quantitative technique that employs high-resolution, flow-compensated
three-dimensional gradient recalled echo (GRE) sequence derived phase images to
enhance small susceptibility variations present between different tissue
compartments on the corresponding magnitude images.3 On SWI,
susceptibility-based signals within tumor beds are visible as low signal
intensity with fine linear or dot-like structures with or without
conglomeration. It is
believed that susceptibility variations within brain tumors are related to
different forms of iron in blood products caused by extensive vascular
proliferation, microhemorrhages, or small vessels.4-6 However, these
tumor-related susceptibility variations may be also caused by calcifications
secondary to presence of oligodendroglial components.7 Quantitative
susceptibility mapping (QSM) offers a highly sensitive tool for iron detection
and quantification by deconvolving
the phase images. 8,9
While paramagnetic (e.g., iron) and
diamagnetic materials (e.g., calcium) present low signal intensity on SWI,
these susceptibility sources can be well-differentiated on corresponding QSM
with paramagnetic materials presenting high signal and diamagnetic materials
presenting low signal intensities. The purpose of this study is to
demonstrate the presence of distinct geometric patterns of iron deposition in
high and low-grade gliomas using ultra high-field (7T) QSM.Methods
A
total of 6 treatment naïve glioma patients (mean age=42.5±12.7years, M/F=2/4)
were recruited. Based upon histopathological analyses, three patients had
high-grade glioma (grade-4 astrocytoma) and two patients had low-grade glioma
[(grade-2 astrocytoma (n=1) and grade-2 oligodendroglioma (n=1)]. One patient
was diagnosed with a low-grade glioma by neuroimaging findings. All patients
underwent MR imaging on a 7T scanner prior to surgical resection. The imaging
protocol included conventional T1-weighted MPRAGE and T2-FLAIR sequences.
Additionally, high-resolution, flow compensated 3D-susceptibility weighted
imaging (3D-SWI) was acquired (in-plane resolution=0.5x0.5mm2, slice
thickness=2mm). Susceptibility weighted imaging and mapping (SWIM) algorithm
developed by Haacke’s group10 was used to reconstruct QSM maps from
3D-SWI data. Gliomas were classified as “iron-laden” if they demonstrated
hypointensity on SWI and hyperintensity on QSM. Gliomas were classified as
“non-iron-laden” if they were iso-intense/hyperintense on SWI and isointense on
QSM.Results
Anatomical
images, SWI and QSM from a representative case of glioma are shown in figure
1. Three morphologically distinct patterns were observed. All three
high-grade gliomas were iron-laden and showed hyperintense signal intensity on
QSM in the form of nodular areas of susceptibility (Figure 2). The mean
QSM values from these nodules were 42±15ppb. On the other hand, two low-grade
gliomas had no evidence of iron deposition. However, one low-grade glioma
exhibited a hyperintense peripheral rim on the QSM with a corresponding value
of 26.85ppb (Figure 3). Discussion
In this pilot study, we
report the potential of ultra-high
field (7T) QSM in detecting different signal intensity patterns related
to iron and non-iron pathologies in gliomas. 7T imaging by virtue of increased
signal to noise ratio and spatial resolution increases the conspicuity of the
intratumoral susceptibility signals. By combining information both from
magnitude and phase images, SWI enhances the conspicuity of small susceptibility
variations present between different tissue components. On SWI, rim like pattern in gliomas has been
demonstrated in a mouse model after the injection of iron-oxide based contrast
agents.11 In
comparison to SWI, QSM is a more sensitive tool for iron detection and
quantification by deconvolving the phase images.8.9
The
clinical utility of 7T QSM has not been reported in gliomas previously. While
we observed iron accumulation in the form of nodules (single or multiple
nodules) in high-grade gliomas in the present study, low-grade gliomas were
either non-iron laden or had the iron deposition only along the edges of
lesions indicating relatively well-circumscribed margins. Conclusion
7T QSM may be helpful in distinguishing low from
high-grade gliomas. However, correlative imaging and histochemical analyses
from a larger patient population are required to confirm these findings.Acknowledgements
This work was supported by Research Grants obtained from University
Research Foundation (URF, PI: Sanjeev Chawla, PhD, DABMP) and Penn Center for Precision
Medicine (PCPM, PI: Suyash Mohan, MD, PDCC), Perelman School of Medicine at the
University of Pennsylvania, Philadelphia, USA. References
1.
Verbovšek U, Motaln H, Rotter A, et al. Correction:
Expression Analysis of All Protease Genes Reveals Cathepsin K to Be
Overexpressed in Glioblastoma. PLOS ONE 2015;10:e0142116.
2.
Huang X. Iron overload and its association with cancer risk in
humans: evidence for iron as a carcinogenic metal. Mutat Res. 2003 Dec
10;533(1-2):153-71.
3.
Haacke EM, Mittal S, Wu Z, et al.
Susceptibility-weighted imaging: technical aspects and clinical applications,
part 1. AJNR Am J Neuroradiol 2009;30:19–30.
4.
Li C, Ai B, Li Y, Qi H, Wu L (2010) Susceptibility-weighted imaging in grading brain astrocytomas. Eur J Radiol 75:
e81–85.
5.
Sehgal V, Delproposto Z, Haddar D, Haacke
EM, Sloan AE, et al. (2006) Susceptibility-weighted
imaging to visualize blood products and improve tumor contrast in the study of
brain masses. J Magn Reson Imaging 24: 41–51.
6.
Radbruch A, Wiestler B, Kramp L, Lutz K, Baumer
P, et al. (2012) Differentiation of glioblastoma and
primary CNS lymphomas using susceptibility weighted imaging. Eur J Radiol 2012 Dec 10
7.
He J, Mokhtari K, Sanson M, Marie Y, Kujas M, et
al. (2001) Glioblastomas with an oligodendroglial
component: a pathological and molecular study. J Neuropathol Exp Neurol 60: 863–871.
8.
Reichenbach
JR, Schweser F, Serres B, Deistung A.
Quantitative Susceptibility Mapping: Concepts and Applications. Clin
Neuroradiol. 2015 Oct;25 Suppl 2:225-30.
9.
Chawla S, Kister I, Wuerfel J, et al. Iron and
Non-Iron-Related Characteristics of Multiple Sclerosis and Neuromyelitis Optica
Lesions at 7T MRI. AJNR Am J Neuroradiol 2016;37:1223–30.
10. Haacke EM, Tang J,
Neelavalli J, et al.. Susceptibility mapping as a means to visualize veins
and quantify oxygen saturation. J Magn Reson Imaging 2010;32:663–76.
11. Blasiak B, Landry J, Tyson
R, Sharp J, Iqbal U, Abulrob A, Rushforth D, Matyas J, Ponjevic D, Sutherland
GR, Wolfsberger S, Tomanek B. Molecular susceptibility weighted imaging of the
glioma rim in a mouse model. J Neurosci Methods. 2014 Apr
15;226:132-138.